Skip to main content
Log in

Perfusion-time dependent enhancements of guanabenz- and KCl-induced vasoconstrictions in isolated and perfused dog pulmonary veins

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

The responses of the isolated canine pulmonary vein to guanabenz and to potassium chloride (KCl) were examined by means of the cannula-inserting method. The vessel was perfused by Krebs-Ringer bicarbonate solution at a constant flow rate at 37°C. In the early stage (within 2–3 hours of the perfusion period), guanabenz induced a dose-dependent vasoconstriction, whereas high doses of KCl caused, at most, a slight vasoconstriction. At the late stage (within 8–11 hours of the perfusion period), the dose-response curve for guanabenz was shifted to the left and the maximum response became approximately 3-fold larger than that in the early stage. Vasoconstriction in response to KCl was observed in 8 out of 11 preparations (73%) in the late stage. In both early and late stages, guanabenz-induced responses were similarly antagonized by DG-5128 (a selective α2-adrenoceptor antagonist) but not by bunazosin (a selective α1-adrenoceptor antagonist). Diltiazem caused an inhibition of guanabenz-induced constrictions, particularly in the late stage. KCl-induced vasoconstriction was not affected by bunazosin or DG-5128, but was markedly suppressed by diltiazem. In preparations in which the endothelium was removed by intraluminal treatment with saponin, the changes in guanabenz- and KCl-induced responses, which were dependent on the perfusion time, were not modified in either stage.

Our results suggest that α2-adrenoceptor-mediated vasoconstriction is enhanced in a perfusion-time-dependent manner in the isolated and perfused canine pulmonary vein. These enhanced responses mediated by latent α2-adrenoceptors are dependent on the influx of extracellular calcium ions. Because the removal of endothelial cells by saponin did not affect the time-dependent enhancement of the response to guanabenz, the removal of endothelial cells by prolonged perfusion may play little part in the time-dependent enhancement of the α2-adrenoceptor-mediated response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Langer SZ (1974) Presynaptic regulation of cathecholamine release. Biochem Pharmacol 23: 1793–1800

    PubMed  Google Scholar 

  2. Berthelsen S, Pettinger WA (1977) A functional basis for classification of α-adrenergic receptors. Life Sci 21: 595–606

    PubMed  Google Scholar 

  3. Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic α-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol 67: 207–215

    PubMed  Google Scholar 

  4. Hyman AL, Kadowitz PJ (1985) Evidence for existence of postjunctional α1- and α2-adrenoceptors in cat pulmonary vascular bed. Am J Physiol 249: H891-H898

    PubMed  Google Scholar 

  5. Shebuski RJ, Fujita T, Ruffolo RR Jr (1986) Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog. J Pharmacol Exp Ther 238: 217–223

    PubMed  Google Scholar 

  6. Ruffolo RR Jr, Yaden EL, Waddell JE (1980) Receptor interactions of imidazolines. V. Clonidine differentiates postsynaptic alpha adrenergic receptor subtypes in tissues from the rat. J Pharmacol Exp Ther 213: 557–561

    PubMed  Google Scholar 

  7. Drew GM (1980) Postsynaptic α2-adrenoceptors mediate pressor responses to 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (M-7). Eur J Pharmacol 65: 85–87

    PubMed  Google Scholar 

  8. De Mey J, Vanhoutte PM (1981) Uneven distribution of postjunctional alpha1- and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48: 875–884

    PubMed  Google Scholar 

  9. Ito T, Chiba S (1985) Existence of two types of postjunctional alpha adrenoceptors in the isolated canine intermediate auricular artery. J Pharmacol Exp Ther 234: 698–702

    PubMed  Google Scholar 

  10. Han C, Abel PW, Minneman KP (1987) α1-Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 329: 333–335

    PubMed  Google Scholar 

  11. Bylund DB (1981) Comparison of [3H]clonidine and [3H]yohimbine binding: Possible subtypes of alpha-2 adrenergic receptors. Pharmacologist 23: 215

    Google Scholar 

  12. Bylund DB (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav 22: 835–843

    PubMed  Google Scholar 

  13. Cheung Y-D, Barnett DB, Nahorski SR (1982) [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: Possible heterogeneity of α2-adrenoceptors. Eur J Pharmacol 84: 79–85

    PubMed  Google Scholar 

  14. Bylund DB, Ray-Prenger C, Murphy TJ (1988) Alpha-2A and alpha-2B adrenergic receptor subtypes: Antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245: 600–607

    PubMed  Google Scholar 

  15. Haniuda M, Chiba S (1989) Time-dependent enhancement of xylazine-induced vasoconstriction in isolated and perfused canine pulmonary vein. J Pharmacol Exp Ther 249: 340–347

    PubMed  Google Scholar 

  16. Langer SZ (1980) Presynaptic regulation of the release of cathecholamines. Pharmacol Rev 32: 337–362

    PubMed  Google Scholar 

  17. Tsuji T, Chiba S (1984) Potentiating effect of methysergide on norepinephrine-induced constriction of the isolated internal carotid artery of the dog. Jpn J Pharmacol 34: 95–100

    PubMed  Google Scholar 

  18. Chiba S, Tsukada M (1986) Comparison of vasoconstrictor actions of norepinephrine and potassium chloride before and after damage of endothelium by saponin. Heart Vessels 2: 1–5

    PubMed  Google Scholar 

  19. Shoji T, Tsuru H, Shigei T (1983) A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins. Naunyn Schmiedebergs Arch Pharmacol 324: 246–255

    PubMed  Google Scholar 

  20. Shebuski RI, Ohlstein EH, Smith JM, Ruffolo RR Jr (1987) Enhanced pulmonary alpha-2 adrenoceptor responsiveness under conditions of elevated pulmonary vascular tone, J Pharmacol Exp Ther 242: 158–165

    PubMed  Google Scholar 

  21. Hyman Al, Kadowitz PJ (1986) Enhancement ofα- andβ-adrenoceptor responses by elevations in vascular tone in pulmonary circulation. Am J Physiol 250: H1109-H1116

    PubMed  Google Scholar 

  22. Joiner PD, Kadowitz PJ, Hughes JP, Hyman AL (1975) NE and ACh responses of intrapulmonary vessels from dog, swine, sheep, and man. Am J Physiol 228: 1821–1827

    PubMed  Google Scholar 

  23. Chiba S, Tsuji T (1985) Vascular responsiveness of isolated, perfused basilar arteries in dogs and monkeys. Tohoku J Exp Med 146: 363–370

    PubMed  Google Scholar 

  24. Nakane T, Chiba S (1988) Comparative study of direct coronary vascular responses to diltiazem, adrenergicβ-blockers and other vasodilators in isolated, perfused dog and monkey coronary arteries. Arch Int Pharmacodyn Ther 291: 153–162

    PubMed  Google Scholar 

  25. Chiba S, Kawai K (1987) Responses of isolated canine and simian femoral arteries and veins to phenylephrine, xylazine and KCl after removal of endothelium. J Auton Pharmacol 7: 3–10

    PubMed  Google Scholar 

  26. Van Zwieten PA, Van Meel JCA, Timmermans PBMWM (1982) Calcium antagonists andα 2-adrenoceptors: Possible role of extracellular calcium ions inα 2-adrenoceptor-mediated vasoconstriction. J Cardiovasc Pharmacol 4: S273-S279

    PubMed  Google Scholar 

  27. Cavero I, Shepperson N, Lefevre-Borg F, Langer SZ (1983) Differential inhibition of vascular smooth muscle responses toα 1- andα 2-adrenoceptor agonists by diltiazem and verapamil. Circ Res 52 (Suppl. I): 69–76

    Google Scholar 

  28. Godfraind T, Miller RC, Socrates Rima J (1982) Selectiveα 1- andα 2-adrenoceptor agonist-induced contractions and45Ca fluxes in the rat isolated aorta. Br J Pharmacol 77: 597–604

    PubMed  Google Scholar 

  29. Verbeuren TJ, Jordaens FH, Bult H, Herman AG (1988) The endothelium inhibits the penetration of serotonin and norepinephrine in the isolated canine saphenous vein. J Pharmacol Exp Ther 244: 276–282

    PubMed  Google Scholar 

  30. Rimele TJ, Vanhoutte PM (1983) Effects of inhibitors of arachidonic acid metabolism and calcium entry on responses to acetylcholine, potassium and norepinephrine in the isolated canine saphenous vein. J Pharmacol Exp Ther 225: 720–728

    PubMed  Google Scholar 

  31. Miller VM, Vanhoutte PM (1985) Endothelialα 2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur J Pharmacol 118: 123–129

    PubMed  Google Scholar 

  32. Kenakin TP (1984) The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br J Pharmacol 81: 131–141

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haniuda, M., Chiba, S. Perfusion-time dependent enhancements of guanabenz- and KCl-induced vasoconstrictions in isolated and perfused dog pulmonary veins. Heart Vessels 5, 212–218 (1990). https://doi.org/10.1007/BF02058692

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02058692

Key words

Navigation